\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ physical\\ examination\\,\\ patient\\ had\\ mild\\ fever\\,\\ a\\ few\\ oral\\ ulcers\\,\\ asymmetric\\ arthritis\\ of\\ hands\\ and\\ feet\\ with\\ clinical\\ inflammation\\ and\\ erythema\\.\\ \\ laboratory\\ studies\\ show\\ hla\\-b27\\ as\\ positive\\.\ \(0\)\
\-\ symptomatic\\ treatment\\ is\\ high\\ doses\\ of\\ non\\-steroidal\\ anti\\-inflammatory\\ drugs\\ such\\ as\\ indomethacin\\.\\ \\ intra\\-articular\\ steroid\\ injections\\ may\\ be\\ helpful\\ in\\ patients\\ w\\/\\ large\\ joint\\ effusions\\.\ \(0\)\
\-\ ap\\ of\\ the\\ feet\\ shows\\ joint\\ space\\ narrowing\\ and\\ proliferative\\ changes\\ at\\ first\\ metatarsophalangeal\\ joint\\ \\(left\\ greater\\ than\\ right\\)\\ with\\ subluxations\\ at\\ the\\ metatarsophalangeal\\ joints\\ of\\ both\\ feet\\.\ \(0\)\
\-\ reiter\\â\\€\\™s\\ syndrome\ \(0\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ reiter\\â\\€\\™s\\ syndrome\ \(0\)\
\-\ ankylosing\\ spondylitis\ \(23\)\
\-\ patient\\â\\€\\™s\\ chief\\ complaint\\ was\\ initially\\ hand\\ and\\ wrist\\ pain\\ although\\ radiographs\\ of\\ the\\ hands\\ did\\ not\\ show\\ significant\\ findings\\.\\ remote\\ history\\ of\\ gastroenteritis\\.\ \(0\)\
\-\ five\\ years\\ prior\\ to\\ admission\\,\\ patient\\ was\\ one\\ of\\ a\\ group\\ of\\ police\\ officers\\ who\\ had\\ acute\\ gastroenteritis\\ secondary\\ to\\ a\\ salmonella\\ typhimurium\\ outbreak\\ during\\ a\\ vip\\ visit\\.\\ \\ within\\ three\\ months\\,\\ 27\\ police\\ officers\\ developed\\ acute\\ arthritis\\,\\ with\\ subsequent\\ resolution\\ in\\ about\\ one\\-third\\ of\\ patients\\ over\\ several\\ months\\.\\ \\ within\\ three\\ months\\,\\ 27\\ police\\ officers\\ developed\\ acute\\ arthritis\\,\\ with\\ subsequent\\ resolution\\ in\\ about\\ one\\-third\\ of\\ patients\\ over\\ several\\ months\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ police\\:\\ 0\\.12900758669219267\ \(0\)\
\-\ officers\\:\\ 0\\.12900758669219267\ \(0\)\
\-\ arthritis\\:\\ 0\\.07123380390327774\ \(0\)\
\-\ metatarsophalangeal\\:\\ 0\\.06456872045492955\ \(0\)\
\-\ feet\\:\\ 0\\.06399317806062706\ \(0\)\
\-\ one\\-third\\:\\ 0\\.05958505583282232\ \(0\)\
\-\ reiter\\:\\ 0\\.057278823851707884\ \(0\)\
\-\ gastroenteritis\\:\\ 0\\.057278823851707884\ \(0\)\
\-\ months\\:\\ 0\\.04554031794517204\ \(0\)\
\-\ hands\\:\\ 0\\.04313238311506399\ \(0\)\
\-\ typhimurium\\:\\ 0\\.04300252889739755\ \(0\)\
\-\ outbreak\\:\\ 0\\.04300252889739755\ \(0\)\
\-\ vip\\:\\ 0\\.04300252889739755\ \(0\)\
\-\ joint\\:\\ 0\\.04044042812256704\ \(0\)\
\-\ 27\\:\\ 0\\.03866817717118908\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.037376001067982285\ \(0\)\
\-\ resolution\\:\\ 0\\.03595726545408219\ \(0\)\
\-\ s\\:\\ 0\\.035864892689481766\ \(0\)\
\-\ non\\-steroidal\\:\\ 0\\.03515161225137755\ \(0\)\
\-\ indomethacin\\:\\ 0\\.03351028426785944\ \(0\)\
\-\ subluxations\\:\\ 0\\.03351028426785944\ \(0\)\
\-\ hla\\-b27\\:\\ 0\\.03285891162091055\ \(0\)\
\-\ subsequent\\:\\ 0\\.032454445832290846\ \(0\)\
\-\ patients\\:\\ 0\\.032364506332185745\ \(0\)\
\-\ about\\:\\ 0\\.03213714640101709\ \(0\)\
\-\ developed\\:\\ 0\\.032098199852046\ \(0\)\
\-\ salmonella\\:\\ 0\\.03177040649254855\ \(0\)\
\-\ proliferative\\:\\ 0\\.03130547878618599\ \(0\)\
\-\ acute\\:\\ 0\\.0308762828649731\ \(0\)\
\-\ doses\\:\\ 0\\.02979252791641116\ \(0\)\
\-\ three\\:\\ 0\\.02810365100826254\ \(0\)\
\-\ several\\:\\ 0\\.026800905714364758\ \(0\)\
\-\ anti\\-inflammatory\\:\\ 0\\.026411322157582157\ \(0\)\
\-\ intra\\-articular\\:\\ 0\\.026096500103252544\ \(0\)\
\-\ injections\\:\\ 0\\.025946394451219598\ \(0\)\
\-\ show\\:\\ 0\\.025591765214552448\ \(0\)\
\-\ ankylosing\\:\\ 0\\.02525820616702494\ \(0\)\
\-\ psoriatic\\:\\ 0\\.025131496477252938\ \(0\)\
\-\ spondylitis\\:\\ 0\\.024887543206157027\ \(0\)\
\-\ chief\\:\\ 0\\.024655211259867978\ \(0\)\
\-\ ulcers\\:\\ 0\\.024543067268527986\ \(0\)\
\-\ remote\\:\\ 0\\.02411862152711516\ \(0\)\
\-\ visit\\:\\ 0\\.023919489846528547\ \(0\)\
\-\ syndrome\\:\\ 0\\.02384299099253309\ \(0\)\
\-\ drugs\\:\\ 0\\.023030116398753162\ \(0\)\
\-\ steroid\\:\\ 0\\.02200708941835282\ \(0\)\
\-\ group\\:\\ 0\\.02168814912926574\ \(0\)\
\-\ w\\/\\:\\ 0\\.021626789216061544\ \(0\)\
\-\ helpful\\:\\ 0\\.021566191557531995\ \(0\)\
\-\ effusions\\:\\ 0\\.021274005501038976\ \(0\)\
\-\ over\\:\\ 0\\.021225781367219147\ \(0\)\
\-\ five\\:\\ 0\\.020788495279833938\ \(0\)\
\-\ erythema\\:\\ 0\\.0204897458884158\ \(0\)\
\-\ asymmetric\\:\\ 0\\.02025404551148503\ \(0\)\
\-\ complaint\\:\\ 0\\.01925845840737032\ \(0\)\
\-\ wrist\\:\\ 0\\.01925845840737032\ \(0\)\
\-\ joints\\:\\ 0\\.019074359246478385\ \(0\)\
\-\ few\\:\\ 0\\.01875953719214877\ \(0\)\
\-\ admission\\:\\ 0\\.018369084959594932\ \(0\)\
\-\ had\\:\\ 0\\.017988778724299593\ \(0\)\
\-\ inflammation\\:\\ 0\\.017725535969143478\ \(0\)\
\-\ oral\\:\\ 0\\.017563817884670794\ \(0\)\
\-\ hand\\:\\ 0\\.017132748858084988\ \(0\)\
\-\ initially\\:\\ 0\\.016965757776903317\ \(0\)\
\-\ narrowing\\:\\ 0\\.016714374117804864\ \(0\)\
\-\ symptomatic\\:\\ 0\\.016560894754605912\ \(0\)\
\-\ within\\:\\ 0\\.015903721057425185\ \(0\)\
\-\ greater\\:\\ 0\\.015657152964246347\ \(0\)\
\-\ studies\\:\\ 0\\.015568297159898341\ \(0\)\
\-\ laboratory\\:\\ 0\\.015361423101727152\ \(0\)\
\-\ ap\\:\\ 0\\.015244677900694819\ \(0\)\
\-\ did\\:\\ 0\\.015050822638989872\ \(0\)\
\-\ fever\\:\\ 0\\.014103720129521786\ \(0\)\
\-\ although\\:\\ 0\\.01407770380769075\ \(0\)\
\-\ first\\:\\ 0\\.013987724072126109\ \(0\)\
\-\ space\\:\\ 0\\.013788082961349438\ \(0\)\
\-\ positive\\:\\ 0\\.013526271172117642\ \(0\)\
\-\ radiographs\\:\\ 0\\.01320132117659577\ \(0\)\
\-\ such\\:\\ 0\\.013030891657760255\ \(0\)\
\-\ examination\\:\\ 0\\.012958161148656416\ \(0\)\
\-\ clinical\\:\\ 0\\.012825901463736605\ \(0\)\
\-\ during\\:\\ 0\\.012756142682555162\ \(0\)\
\-\ as\\:\\ 0\\.012610512252625636\ \(0\)\
\-\ patient\\:\\ 0\\.012535491671947141\ \(0\)\
\-\ years\\:\\ 0\\.012240210424480402\ \(0\)\
\-\ changes\\:\\ 0\\.011946575493829563\ \(0\)\
\-\ secondary\\:\\ 0\\.01165380471467711\ \(0\)\
\-\ shows\\:\\ 0\\.01146035951087258\ \(0\)\
\-\ high\\:\\ 0\\.01140754176135032\ \(0\)\
\-\ one\\:\\ 0\\.011296250650295825\ \(0\)\
\-\ at\\:\\ 0\\.011295250271528126\ \(0\)\
\-\ significant\\:\\ 0\\.011209010492947431\ \(0\)\
\-\ mild\\:\\ 0\\.010976846116737254\ \(0\)\
\-\ than\\:\\ 0\\.010922189536186701\ \(0\)\
\-\ who\\:\\ 0\\.010868138581179035\ \(0\)\
\-\ prior\\:\\ 0\\.010702989132694456\ \(0\)\
\-\ both\\:\\ 0\\.010644878003346934\ \(0\)\
\-\ \\,\\:\\ 0\\.010564295239699019\ \(0\)\
\-\ physical\\:\\ 0\\.010226854973567016\ \(0\)\
\-\ was\\:\\ 0\\.009641731924035968\ \(0\)\
\-\ may\\:\\ 0\\.00914306521413719\ \(0\)\
\-\ large\\:\\ 0\\.009114841130883315\ \(0\)\
\-\ findings\\:\\ 0\\.00887237529653639\ \(0\)\
\-\ treatment\\:\\ 0\\.008437155900492132\ \(0\)\
\-\ a\\:\\ 0\\.007738532718411732\ \(0\)\
\-\ be\\:\\ 0\\.00642808157728746\ \(0\)\
\-\ in\\:\\ 0\\.006166788733759828\ \(0\)\
\-\ not\\:\\ 0\\.006023505715814319\ \(0\)\
\-\ history\\:\\ 0\\.005757144086376016\ \(0\)\
\-\ of\\:\\ 0\\.005683112234048216\ \(0\)\
\-\ pain\\:\\ 0\\.005090771548930413\ \(0\)\
\-\ left\\:\\ 0\\.004663928142794706\ \(0\)\
\-\ right\\:\\ 0\\.004398203459075203\ \(0\)\
\-\ to\\:\\ 0\\.004166518131151086\ \(0\)\
\-\ on\\:\\ 0\\.003531175670075259\ \(0\)\
\-\ \\(\\:\\ 0\\.0035237157377749294\ \(0\)\
\-\ and\\:\\ 0\\.003512370843555482\ \(0\)\
\-\ \\)\\:\\ 0\\.003480671668845391\ \(0\)\
\-\ is\\:\\ 0\\.0027428818457791494\ \(0\)\
\-\ with\\:\\ 0\\.002283008313949068\ \(0\)\
\-\ the\\:\\ 0\\.0020231602639555\ \(0\)\
\-\ \\.\\:\\ 0\\.0017316846876754281\ \(0\)\
